查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1233085

2023-2030 年按类型（单克隆）、服务（抗体开发）、来源（小鼠）、应用、最终用途、地区、细分市场预测的定制抗体市场规模、份额和趋势分析报告

Custom Antibody Market Size, Share & Trends Analysis Report By Type (Monoclonal), By Service (Antibody Development), By Source (Mice), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

定制抗体市场增长和趋势

Grand View Research, Inc. 最新报告显示，2023 年至 2030 年全球定制抗体市场规模将以 9.7% 的复合年增长率增长，2030 年将达到 3.017 亿，预计将到达美国美元。

预计在预测期内市场将出现显着增长。 这种增长归因于生物技术初创企业增加用于开发创新产品的资金。 此外，新兴市场对个性化诊断和治疗的认识不断提高也有助于定制抗体市场的增长。

公司增加投资以扩大抗体开发和生产服务预计将支持市场增长。 例如，Absolute Antibody Ltd. 已进入定制抗体测序、表达和工程服务领域。 2022 年 8 月，该公司宣布将通过增加更多实验室空间和投资下一代测序、纯化和表达等自动化技术来扩大其製造设施。 这种扩展有望改善重组抗体製造工作流程。

同样，公司也在改进定制抗体的应用。 根据 2023 年 1 月发表的一篇文章，MilliporeSigma 计划利用其 Cell Marque Tissue Diagnostics 技术开发新抗体。 兔多克隆抗体被定制用于检测 ATRX，一种神经胶质瘤。 神经胶质瘤占中枢神经系统肿瘤的 30%。 该抗体有望扩大我们在神经病理学领域的产品组合。

通过监管机构的拨款和公司提供的折扣服务对学术研究机构的财政支持预计将在预测期内促进定制抗体的发现和研究。 例如，Absolute antibody 提供 10% 的定制服务折扣，AltaBioscience 也提供类似的限时折扣。 此类折扣有望降低研究人员的总体生产成本。

然而，製造定制单克隆抗体的高成本预计将抑制定制抗体市场的增长。 平均估计成本约为 6,000 美元至 15,000 美元。 这种成本是各种初创企业和新兴参与者进入市场的障碍。 然而，通过开发可靠的製造试剂和技术，可以避免初始成本并降低成本。

定制抗体市场报告亮点

  • 从类型上看，2022年单克隆抗体领域有望比多克隆抗体领域相对成熟，成为主导领域。 预计公司增加研发投资将支持定制抗体市场的增长。
  • 按服务划分，到 2022 年，抗体开发领域将占据定制抗体市场的大部分份额。 该服务领域参与者的数量和类型超过抗体生产和碎片化，这有助于增长。
  • 根据来源，鼠标细分市场预计在预测期内增长最快。 这是因为小鼠是广泛使用的实验动物，可以很容易地用于定制抗体的生成。
  • 按应用划分，传染病将成为 2022 年市场份额最大的主要细分市场，预计这一趋势将在预测期内持续存在。 这种增长可归因于发展中国家新出现的传染病。
  • 按最终用途划分，学术和研究部门预计将成为 2022 年增长最快、市场份额最大的部分。 这种增长是由政府和企业补贴和资金的增加推动的。
  • 北美在市场中具有强大的区域地位，2022 年占总市场份额的 44.91%。 不断上升的癌症发病率和高昂的研发成本促使公司在该地区开发产品。

内容

第一章调查方法及范围

  • 信息采购
  • 信息或数据分析
  • 市场范围和细分定义
  • 市场模型
    • 市场调查，按公司市场份额
    • 区域分析

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第 3 章市场变量、趋势和范围

  • 市场细分和范围
  • 市场系列展望
    • 母公司市场展望
    • 相关/子公司市场前景
  • 市场趋势和前景
  • 市场动态
    • 对定制诊断和治疗的需求不断增加
    • 玩家之间的协作和伙伴关係轻鬆
    • 监管机构的举措增加
  • 市场製约因素分析
    • 生产成本高
  • 2022 年渗透率和增长前景图
  • 商业环境分析
    • SWOT 分析；按因素（政治和法律、经济和技术）
    • 波特的五力分析
  • COVID-19 影响分析

第 4 章业务分析类型

  • 定制抗体市场：变化分析
  • 单克隆抗体
  • 多克隆抗体
  • 重组抗体
  • 其他

第5章服务业务分析

  • 定制抗体市场：服务波动分析
  • 抗体开发
  • 抗体生产和纯化
  • 抗体的片段化和标记

第6章来源业务分析

  • 定制抗体市场：来源差异分析
  • 鼠标
  • 兔子
  • 其他

第 7 章应用业务分析

  • 定制抗体市场：应用差异分析
  • 肿瘤学
  • 感染
  • 神经学
  • 干细胞
  • 免疫学
  • 心血管疾病
  • 其他

第 8 章最终用户业务分析

  • 定制抗体市场：最终用户差异分析
  • 製药和生物技术公司
  • 学术和研究机构
  • 首席风险官
  • 医院和诊所

第9章区域业务分析

  • 2022 年和 2030 年按地区划分的定制抗体市场份额
  • 北美
    • SWOT 分析
    • 美国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 加拿大
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 欧洲
    • SWOT 分析
    • 德国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 英国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 法国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 意大利
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 西班牙
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 丹麦
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 瑞典
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 挪威
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 亚太地区
    • SWOT 分析
    • 日本
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 中国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 印度
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 韩国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 澳大利亚
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 泰国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 拉丁美洲
    • SWOT 分析
    • 巴西
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 墨西哥
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 阿根廷
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
  • 多边环境协定
    • SWOT 分析
    • 南非
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 沙特阿拉伯
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 阿拉伯联合酋长国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景
    • 科威特
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
      • 赎回场景

第10章竞争格局

  • 参与公司概览
    • Thermo Fisher Scientific Inc.
    • Creative Diagnostics
    • Abcam plc
    • Bio-Rad Laboratories, Inc
    • Kaneka Eurogentec S.A.
    • YenZym Antibodies, LLC.
    • Abmart
    • Labcorp Drug Development
    • LifeSpan BioSciences, Inc
    • GenScript
  • 财务业绩
  • 参与公司分类
    • 市场领导者
    • 2022 年定制抗体市场份额分析
    • 战略规划
      • 分机
      • 得到
      • 协作
      • 推出产品/服务
      • 伙伴关係
      • 其他
Product Code: GVR-4-68040-030-3

Custom Antibody Market Growth & Trends:

The global custom antibody market size is expected to reach USD 301.7 million by 2030, expanding at a CAGR of 9.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness substantial growth during the forecast period. This growth is attributed to the increasing fundraising by biotech startups for developing innovative products. Additionally, rising awareness of personalized diagnostic and therapeutic treatments in emerging markets is also a contributing factor to the growth of the custom antibody market.

Increasing investment by the players to expand their services in the development and production of antibodies is likely to support the growth of the market. For instance, Absolute Antibody Ltd. is into the services of custom antibody sequencing, expression, and engineering. In August 2022, the company announced the expansion of its manufacturing facility by increasing the lab space and investing in automated technology such as next-generation sequencing, purification, and expression. The expansion is expected to improve the production workflow for recombinant antibodies.

Similarly, companies are also improving the application of custom antibodies. According to an article published in January 2023, MilliporeSigma is planning to develop new antibodies through its Cell Marque Tissue Diagnostics technology. The rabbit polyclonal antibody is customized to detect a type of glioma, ATRX. Gliomas account for 30% of tumors in the central nervous system. Through this antibody, the company is anticipated to expand its portfolio in neuropathology.

Monetary support to academic and research institutions through grants from regulatory bodies and discount offers on services by companies are anticipated to enhance custom antibody discovery and research during the forecast period. For instance, Absolute antibody offers 10% off on custom services, while a similar discount is also offered by AltaBioscience for a limited time period. The discounts are expected to reduce the overall cost of production for researchers.

However, the high cost of producing custom monoclonal antibodies is expected to restrain the growth of the custom antibody market. The average estimated cost is around USD 6,000 to 15,000. The cost acts as a market entry barrier for various startups and emerging players. However, the cost can be reduced by developing reliable production reagents and techniques to avoid the upfront cost.

Custom Antibody Market Report Highlights:

  • By type, the monoclonal antibody segment is considered to be a relatively more mature and dominant segment than polyclonal in 2022. The increasing R&D investment by companies is expected to support the growth of the custom antibody market
  • By service, the antibody development segment captured the majority of the custom antibody market share in 2022. The number and type of players in this service segment are greater than antibody production and fragmentation, which is contributing to the growth
  • By source, the mice segment is estimated to be the fastest-growing during the forecast period. This is because mice are widely available lab animals and can be easily used for custom antibody production
  • By application, infectious disease is considered the key segment with the largest market share in 2022, and this trend is likely to be maintained over the forecast period. This growth can be attributed to the emerging infectious diseases in developing countries
  • By end-users, the academic and research institutions segment is estimated to be the fastest-growing segment, with the largest market share in 2022. The growth is attributed to the increasing grants and financial assistance from governments and companies
  • North America has established a strong regional position in the market with 44.91% of the overall market share in 2022. The increasing incidence rate of cancer and high R&D expenditure are encouraging companies to undertake product development in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing demand for customized diagnostics and therapeutics
    • 3.4.2. Ease of collaboration and partnerships amongst players
    • 3.4.3. Increasing initiatives by the regulatory bodies
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of production
  • 3.6. Penetration and Growth Prospect Mapping 2022
  • 3.7. Business Environment Analysis
    • 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.7.2. Porter's Five Forces Analysis
  • 3.8. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Custom Antibody Market: Type Movement Analysis
  • 4.2. Monoclonal Antibodies
    • 4.2.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Million)
  • 4.3. Polyclonal Antibodies
    • 4.3.1. Polyclonal Antibodies Market, 2018 - 2030 (USD Million)
  • 4.4. Recombinant Antibodies
    • 4.4.1. Recombinant Antibodies Market, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Service Business Analysis

  • 5.1. Custom Antibody Market: Service Movement Analysis
  • 5.2. Antibody Development
    • 5.2.1. Antibody Development Market, 2018 - 2030 (USD Million)
  • 5.3. Antibody Production & Purification
    • 5.3.1. Antibody Production & Purification Market, 2018 - 2030 (USD Million)
  • 5.4. Antibody Fragmentation & Labelling
    • 5.4.1. Antibody Fragmentation & Labelling Market, 2018 - 2030 (USD Million)

Chapter 6. Source Business Analysis

  • 6.1. Custom Antibody Market: Source Movement Analysis
  • 6.2. Mice
    • 6.2.1. Mice Market, 2018 - 2030 (USD Million)
  • 6.3. Rabbit
    • 6.3.1. Rabbit Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Custom Antibody Market: Application Movement Analysis
  • 7.2. Oncology
    • 7.2.1. Oncology Market, 2018 - 2030 (USD Million)
  • 7.3. Infectious Diseases
    • 7.3.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
  • 7.4. Neurology
    • 7.4.1. Neurology Market, 2018 - 2030 (USD Million)
  • 7.5. Stem cells
    • 7.5.1. Stem cells Market, 2018 - 2030 (USD Million)
  • 7.6. Immunology
    • 7.6.1. Immunology Market, 2018 - 2030 (USD Million)
  • 7.7. Cardiovascular Diseases
    • 7.7.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
  • 7.8. Others
    • 7.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. End-user Business Analysis

  • 8.1. Custom Antibody Market: End-user Movement Analysis
  • 8.2. Pharmaceutical & Biotechnology Companies
    • 8.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 8.3. Academic & Research Institutes
    • 8.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.4. CRO
    • 8.4.1. CRO Market, 2018 - 2030 (USD Million)
  • 8.5. Hospitals and Clinics
    • 8.5.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Custom Antibody Market Share By Region, 2022 & 2030
  • 9.2. North America
    • 9.2.1. SWOT Analysis
    • 9.2.2. North America Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.2.3. U.S.
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Prevalence
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Regulatory Framework
      • 9.2.3.5. Reimbursement Scenario
      • 9.2.3.6. U.S. Custom Antibody Market, 2018 - 2030 (USD MILLION)
    • 9.2.4. Canada
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Target Disease Prevalence
      • 9.2.4.3. Competitive Scenario
      • 9.2.4.4. Regulatory Framework
      • 9.2.4.5. Reimbursement Scenario
      • 9.2.4.6. Canada Custom Antibody Market, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. SWOT Analysis
    • 9.3.2. Europe Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. Germany Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.4. UK
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. UK Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.5. France
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Prevalence
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Regulatory Framework
      • 9.3.5.5. Reimbursement Scenario
      • 9.3.5.6. France Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.6. Italy
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Prevalence
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Regulatory Framework
      • 9.3.6.5. Reimbursement Scenario
      • 9.3.6.6. Italy Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.7. Spain
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Prevalence
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Regulatory Framework
      • 9.3.7.5. Reimbursement Scenario
      • 9.3.7.6. Spain Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Prevalence
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Regulatory Framework
      • 9.3.8.5. Reimbursement Scenario
      • 9.3.8.6. Denmark Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.9. Sweden
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Prevalence
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Regulatory Framework
      • 9.3.9.5. Reimbursement Scenario
      • 9.3.9.6. Sweden Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.3.10. Norway
      • 9.3.10.1. Key Country Dynamics
      • 9.3.10.2. Target Disease Prevalence
      • 9.3.10.3. Competitive Scenario
      • 9.3.10.4. Regulatory Framework
      • 9.3.10.5. Reimbursement Scenario
      • 9.3.10.6. Norway Custom Antibody Market, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. SWOT Analysis
    • 9.4.2. Asia Pacific Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. Japan Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.4.4. China
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. China Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.4.5. India
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. India Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. South Korea Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.4.7. Australia
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Australia Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.4.8. Thailand
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Target Disease Prevalence
      • 9.4.8.3. Competitive Scenario
      • 9.4.8.4. Regulatory Framework
      • 9.4.8.5. Reimbursement Scenario
      • 9.4.8.6. Thailand Custom Antibody Market, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. SWOT Analysis
    • 9.5.2. Latin America Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.5.3. Brazil
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. Brazil Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.5.4. Mexico
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Reimbursement Scenario
      • 9.5.4.6. Mexico Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.5.5. Argentina
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Target Disease Prevalence
      • 9.5.5.3. Competitive Scenario
      • 9.5.5.4. Regulatory Framework
      • 9.5.5.5. Reimbursement Scenario
      • 9.5.5.6. Argentina Custom Antibody Market, 2018 - 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. SWOT Analysis
    • 9.6.2. MEA Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.6.3. South Africa
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. South Africa Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.6.4. Saudi Arabia
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. Regulatory Framework
      • 9.6.4.5. Reimbursement Scenario
      • 9.6.4.6. Saudi Arabia Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.6.5. UAE
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Regulatory Framework
      • 9.6.5.5. Reimbursement Scenario
      • 9.6.5.6. UAE Custom Antibody Market, 2018 - 2030 (USD Million)
    • 9.6.6. Kuwait
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Target Disease Prevalence
      • 9.6.6.3. Competitive Scenario
      • 9.6.6.4. Regulatory Framework
      • 9.6.6.5. Reimbursement Scenario
      • 9.6.6.6. Kuwait Custom Antibody Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant's overview
    • 10.1.1. Thermo Fisher Scientific Inc.
    • 10.1.2. Creative Diagnostics
    • 10.1.3. Abcam plc
    • 10.1.4. Bio-Rad Laboratories, Inc
    • 10.1.5. Kaneka Eurogentec S.A.
    • 10.1.6. YenZym Antibodies, LLC.
    • 10.1.7. Abmart
    • 10.1.8. Labcorp Drug Development
    • 10.1.9. LifeSpan BioSciences, Inc
    • 10.1.10. GenScript
  • 10.2. Financial performance
  • 10.3. Participant categorization
    • 10.3.1. Market Leaders
    • 10.3.2. Custom Antibody Market Share Analysis, 2022
    • 10.3.3. Strategy Mapping
      • 10.3.3.1. Expansion
      • 10.3.3.2. Acquisition
      • 10.3.3.3. Collaborations
      • 10.3.3.4. Product/Service Launch
      • 10.3.3.5. Partnerships
      • 10.3.3.6. Others

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 5 Global Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 6 Global Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 7 Global Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 8 Global Custom Antibody Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Custom Antibody Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 11 North America Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 12 North America Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 13 North America Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 14 North America Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 15 U.S. Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 17 U.S. Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 18 U.S. Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 U.S. Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 20 Canada Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 Canada Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 22 Canada Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 23 Canada Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Canada Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 25 Europe Custom Antibody Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 Europe Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 28 Europe Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 29 Europe Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 Europe Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 31 Germany Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 32 Germany Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 33 Germany Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 34 Germany Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 35 Germany Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 36 UK Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 UK Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 38 UK Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 39 UK Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 UK Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 41 France Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 42 France Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 43 France Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 44 France Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 45 France Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 46 Italy Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Italy Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 48 Italy Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 49 Italy Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 50 Italy Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 51 Spain Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 52 Spain Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 53 Spain Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 54 Spain Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Spain Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 56 Denmark Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 57 Denmark Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 58 Denmark Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 59 Denmark Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 Denmark Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 61 Sweden Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 Sweden Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 63 Sweden Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 64 Sweden Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Sweden Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 66 Norway Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 67 Norway Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 68 Norway Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 69 Norway Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Norway Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific Custom Antibody Market, by Country, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 77 China Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 78 China Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 79 China Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 80 China Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 China Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 82 Japan Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 83 Japan Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 84 Japan Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 85 Japan Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 86 Japan Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 87 India Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 India Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 89 India Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 90 India Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 91 India Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 92 South Korea Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 South Korea Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 94 South Korea Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 95 South Korea Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 96 South Korea Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 97 Australia Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 98 Australia Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 99 Australia Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 100 Australia Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 101 Australia Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 102 Thailand Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 103 Thailand Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 104 Thailand Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 105 Thailand Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 106 Thailand Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 107 Latin America Custom Antibody Market, by Country, 2018 - 2030 (USD Million)
  • Table 108 Latin America Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 109 Latin America Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 110 Latin America Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 111 Latin America Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 112 Latin America Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 113 Brazil Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 114 Brazil Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 115 Brazil Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 116 Brazil Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 117 Brazil Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 118 Mexico Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 119 Mexico Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 120 Mexico Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 121 Mexico Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 122 Mexico Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 123 Argentina Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 124 Argentina Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 125 Argentina Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 126 Argentina Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 127 Argentina Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 134 South Africa Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 135 South Africa Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 136 South Africa Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 137 South Africa Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 138 South Africa Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 144 UAE Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 145 UAE Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 146 UAE Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 147 UAE Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
  • Table 148 UAE Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Custom Antibody Market, by End-user, 2018 - 2030 (USD Million) 

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Custom Antibody Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
  • Fig. 16 Global Custom Antibody Market: Type Movement Analysis
  • Fig. 17 Global Custom Antibody Market, for Monoclonal antibodies, 2018 - 2030 (USD Million)
  • Fig. 18 Global Custom Antibody Market, for Polyclonal Antibodies, 2018 - 2030 (USD Million)
  • Fig. 19 Global Custom Antibody Market, for Recombinant Antibodies, 2018 - 2030 (USD Million)
  • Fig. 20 Global Custom Antibody Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 21 Global Custom Antibody Market: Service Movement Analysis
  • Fig. 22 Global Custom Antibody Market, for Antibody development, 2018 - 2030 (USD Million)
  • Fig. 23 Global Custom Antibody Market, for Antibody production & Purification, 2018 - 2030 (USD Million)
  • Fig. 24 Global Custom Antibody Market, for Antibody Fragmentation & labelling, 2018 - 2030 (USD Million)
  • Fig. 25 Global Custom Antibody Market: Source Movement Analysis
  • Fig. 26 Global Custom Antibody Market, for Mice, 2018 - 2030 (USD Million)
  • Fig. 27 Global Custom Antibody Market, for Rabbit, 2018 - 2030 (USD Million)
  • Fig. 28 Global Custom Antibody Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 29 Global Custom Antibody Market: Application Movement Analysis
  • Fig. 30 Global Custom Antibody Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 31 Global Custom Antibody Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 32 Global Custom Antibody Market, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 33 Global Custom Antibody Market, for Stem cells, 2018 - 2030 (USD Million)
  • Fig. 34 Global Custom Antibody Market, for Immunology, 2018 - 2030 (USD Million)
  • Fig. 35 Global Custom Antibody Market, for Cardiovascular Diseases, 2018 - 2030 (USD Million)
  • Fig. 36 Global Custom Antibody Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 37 Global Custom Antibody Market: End-user Movement Analysis
  • Fig. 38 Global Custom Antibody Market, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 39 Global Custom Antibody Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 40 Global Custom Antibody Market, for CRO, 2018 - 2030 (USD Million)
  • Fig. 41 Global Custom Antibody Market, for Hospitals and Clinics, 2018 - 2030 (USD Million)
  • Fig. 42 Regional Marketplace: Key Takeaways
  • Fig. 43 Regional Outlook, 2022 & 2030
  • Fig. 44 Global Custom Antibody Market: Region Movement Analysis
  • Fig. 45 North America Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 48 Europe Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 49 Germany Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 50 UK Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 51 France Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 52 Italy Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 56 Norway Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 58 Japan Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 59 China Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 60 India Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East and Africa Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 71 UAE Custom Antibody Market, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait Custom Antibody Market, 2018 - 2030 (USD Million)